The levels of C3, C3a, and C5a that we have measured in dengue patients (Figures 1 and 2) demonstrated the presence of increased complement activity in DHF patients; these findings are consistent with the levels that have been previously reported in patients with this severe form of disease [3], [11], [13], [14]. This evidence concerns the gene C5 and dengue disease.